title: Optimal clinical risk prediction can be achieved by combining quantitative fetal fibronectin and cervical length, and avoiding thresholds.
authors.affiliation: Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
authors.forename: Georgia N
authors.initials: GN
authors.lastname: Ross
authors.affiliation: Division of Women's Health, King's College London, St Thomas' Hospital, London, UK.
authors.forename: Alexandra E
authors.initials: AE
authors.lastname: Ridout
authors.affiliation: Division of Women's Health, King's College London, St Thomas' Hospital, London, UK.
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Shennan
mesh_terms: D054791:Cervical Length Measurement; D002584:Cervix Uteri; D005353:Fibronectins; D006801:Humans; D007752:Obstetric Labor, Premature; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012306:Risk
chemical_list: D005353:Fibronectins